STUDY OF INCIDENCE AND TREATMENT OUTCOMES OF MEGALOBLASTIC ANAEMIA PRESENTING AS PYREXIAL DISORDER.

Authors

  • Dr. Arvind Agrawal
  • Dr Nalini Humney
  • Dr. Shilpa Kuthe

DOI:

https://doi.org/10.53555/c52t8737

Keywords:

Megaloblastic anemia, Pyrexial disorder, Vitamin B12 deficiency.

Abstract

: Megaloblastic anemia (MA) is an underrecognized cause of Pyrexial disorder ,often triggering extensive investigations for infections or malignancies. Prospective data on its clinical-therapeutic profile remain scarce.

Objectives: 1) Characterize clinical/hematological features of MA presenting as Pyrexial disorder and to evaluate response to vitamin B12.

Methods: A 12-month prospective cohort study (2024–2025) was conducted  at  Lata Mangeshkar Hospital, attached to the N.K.P.Salve Institute of Medical Sciences & Research Centre, Nagpur.Adults (≥18 years) with Pyrexial disorder (fever >101°F for ≥3 days) and MA (Hb <11g/dL /<12g/dL M + MCV>110fL/peripheral smear abnormalities/B 12 <200pg/mL after excluding infections/malignancies were enrolled . Standardized B<sub>12</sub> therapy was administered. Outcomes included fever resolution time, hematological .recovery, and symptom response.

Results: 56 adults with megaloblastic anaemia and Pyrexial disorder, exhibiting a male predominance (57.1%) and mean age of 41.3 ± 14.9 years. Patients presented with prolonged fever (mean 6.8±2.3 days), severe macrocytic anemia (Hb 7.2±1.4 g/dL; MCV 116.4±8.7 fL), and inflammation (92.9% elevated ESR; 89.3% elevated CRP). Fever resolved rapidly after therapy initiation (median 36 hours), with 87.5% afebrile within 48 hours. Hemoglobin significantly increased by Day 7 (8.9±1.3 g/dL, p<0.001) and normalized in 85.7% by Day 28.

Conclusions: MA is a reversible cause of Pyrexial disorder characterized by triad of high-grade fever, macrocytic anemia, and systemic inflammation. Rapid defervescence within 48 hours of B12 therapy serves as a diagnostic-therapeutic indicator. Early empiric hematinic intervention in Pyrexial disorder patients with macrocytosis prevents unnecessary antimicrobial use, reduces diagnostic costs, and mitigates neurological sequelae.

Author Biographies

  • Dr. Arvind Agrawal

    Assistant professor , Department of General Medicine, NKP Salve Institute of Medical Sciences Nagpur,

  • Dr Nalini Humney

    Professor, Department of General Medicine, NKP Salve Institute of Medical Sciences Nagpur.

  • Dr. Shilpa Kuthe

    Associate Professor, Department of General Medicine, NKP Salve Institute of Medical Sciences Nagpur.

References

1. Wickramasinghe SN. Diagnosis of megaloblastic anaemias. Blood Rev. 2006 Nov;20(6):299–318.

2. Siddiqui B, Rabindranath D, Faridi SH, Khan AA, Haiyat S, Eswaran R. Megaloblastic anemia: A common but often neglected cause of pyrexial disorder. J Transl Int Med. 2015 Apr-Jun;3(2):64-67. doi: 10.1515/jtim-2015-0005. Epub 2015 Jun 30.

3. Manuel K, Padhi S, G’boy Varghese R. Pyrexia in a patient with megaloblastic anemia: A case report and literature review. Iran J Med Sci. 2013;38( 2 Suppl):198–201.

4. Hoffbrand HV. Megaloblastic anemia and miscellaneous deficiency anemias. In: Worrell DA, Cox TM, Firth JD, Ben Jr, editor. Oxford Textbook of clinical Medicine. 4. Vol. 3. Oxford: Oxford University Press 2003: 659-75.

5. McKee LC Jr. Fever in megaloblastic anemia. South Med J. 1979 Nov;72(11):1423-4, 1428.

6. Behera V, Kumar R, Agrawal C, Kapoor R, Kaur N, Nair V. Clinico-laboratory Profile and Outcomes of Megaloblastic Anemia presenting as Severe Pyrexial Illness mimicking Tropical Infection. J Assoc Physicians India. 2023 May;71(5):11-12. doi: 10.5005/japi-11001-0222.

7. Negi RC, Kumar J, Kumar V, Singh K, Bharti V, Gupta D, Kashyap R, Raina S. Vitamin B12 deficiency presenting as pyrexia. J Assoc Physicians India. 2011 Jun;59:379-80.

8. Jaina D, Jain P, Aggarwal HK, Kaverappa V, Kumar A. Megaloblastic Anaemia Presenting as Pyrexia: An Interesting Case Report. J Hematol. 2012;1(4-5):102-4.

9. Green R, Datta Mitra A. Megaloblastic Anemias: Nutritional and Other Causes. Med Clin North Am. 2017 Mar;101(2):297-317

10. Stabler SP. Vitamin B12 Deficiency. N Engl J Med. 2013;368(2):149-60.

11. Andrès E, et al. Hematological Manifestations of B12 Deficiency. Expert Rev Hematol. 2022;15(7):671-685.

12. Reynolds EH. Neurological Consequences of Folate Deficiency. Handb Clin Neurol. 2014;120:927-43.

Downloads

Published

2025-11-21

How to Cite

Dr. Arvind Agrawal, Dr Nalini Humney, & Dr. Shilpa Kuthe. (2025). STUDY OF INCIDENCE AND TREATMENT OUTCOMES OF MEGALOBLASTIC ANAEMIA PRESENTING AS PYREXIAL DISORDER. Journal of Population Therapeutics and Clinical Pharmacology, 32(10), 1180-1186. https://doi.org/10.53555/c52t8737
More Citation Formats

Issue

Section

Articles

How to Cite

Dr. Arvind Agrawal, Dr Nalini Humney, & Dr. Shilpa Kuthe. (2025). STUDY OF INCIDENCE AND TREATMENT OUTCOMES OF MEGALOBLASTIC ANAEMIA PRESENTING AS PYREXIAL DISORDER. Journal of Population Therapeutics and Clinical Pharmacology, 32(10), 1180-1186. https://doi.org/10.53555/c52t8737